AzTrials
AzTrials

Preterm Birth ComplicationECAPNCT05827679

Creation and Validation of a Clinical Evaluation Scale for Abdominal Condition of the Premature (ECAP)

An observational study of Preterm Birth Complication and Digestive System Disease, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Every year in France, 60,000 children are born prematurely (before 37 weeks of amenorrhea), and present an immaturity of their various systems, in particular the digestive system. Read more about this study

Who is it for?
Ages 3 to 60 days
How many people
120 participants
Where
1 siteFrance
Study dates
15 Mar 2023to 1 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 60 days
  • All sexes
  • Child

Study population: Newborns born before 37 weeks of amenorrhea, hospitalized in the neonatal intensive care units

Who may be able to join

  • newborns, born prematurely (before 37 weeks of amenorrhea)
  • at least 3 days of life
  • hospitalized in the neonatal intensive care units
  • whose holders of parental authority are able to give free and informed consent to participate in this study

Who cannot join

  • Newborns with congenital pathology such as malformation, genetic or chromosomal abnormality.
  • Newborns whose holders of parental authority are protected by law (under guardianship) or under the age of 18.
  • Rejection of participation by parents

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU clermont-ferrand

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Creation and Validation of a Clinical Evaluation Scale for Abdominal Condition of the Premature

Every year in France, 60,000 children are born prematurely (before 37 weeks of amenorrhea), and present an immaturity of their various systems, in particular the digestive system. This can result in feeding intolerance, which is expressed by abdominal distension, regurgitation or vomiting, irregular transit and abdominal discomfort. This feeding intolerance influences the length of hospitalization and can lead to necrotising enterocolitis, a major complication.

In the Neonatal Intensive Care Units of Clermont-Ferrand hospital center, abdominal massages have been performed by physiotherapists for several years in order to improve the condition of the digestive system. However, the indication for abdominal massage is very dependent on the caregivers in charge of the newborn and the evaluation of the abdominal condition remains subjective with a great variability between examiners. Thus, some newborns will receive massage multiple times a day while others will not.

Read more

Developmental care is essential for these premature infants, especially to avoid over-stimulation. It is important not to add care, such as massage, if it is not needed. It is therefore essential to properly assess the digestive status of premature babies in order to determine whether they have feeding intolerance and whether they require treatment with abdominal massage.

To date, the investigators have not found measurable criteria or existing scales that can describe the digestive status of newborns. The main objective of the study is therefore to create and validate a clinical assessment scale for the abdominal status of preterm infants.

Read the detailed description

This is an observational study with longitudinal follow-up regarding the validation of a scale that the investigators have created.

Inclusions will be made when the patient arrives at the Clermont-Ferrand hospital center in the neonatal intensive care units. The patients will be evaluated daily from the 3rd day of life by the nurse, the physiotherapist and the resident of the service. The evaluation will be carried out at least 8 times over 21 days. If an abdominal massage is performed, an assessment of the abdominal condition by the scale will be necessary before and after each massage by the physiotherapist. Each assessment (by physio, nurse and resident) will be blinded and within a maximum time window of 30 minutes.

The first evaluator clears the patient's abdomen (clothing and diaper removed) and then performs the assessment of the abdomen blindly. A description has been written so that each evaluator can use the ECAP scale under the same conditions and with well-detailed judgment criteria in order to have an evaluation that is as reliable as possible.

The time taken to assess the premature baby's abdomen by the ECAP scale is less than 3 minutes. The evaluator fills out the ECAP assessment table, blindly.

Within the next 30 minutes (the patient's abdominal condition is considered stable during this time), the second and third assessors have to do the same.

These assessments are stored together with each patient's clinical data collection, and then analyzed by statisticians.

Keywords
physiotherapy, abdominal massage
Medical subject headings
Digestive System Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Abdominal assessment scale for Preterm infant (ECAP scale)

    score between 0 and 20

    Measured: up to 18 months

Secondary outcomes (3)
  1. Indication for abdominal massage on ECAP scale

    score on the Clinical Abdominal assessment scale for Preterm infants, between 0 and 20 (higher scores meaning worse outcome)

    Measured: up to 18 months

  2. ECAP scale validity

    term of birth population

    Measured: up to 18 months

  3. impact of massage on ECAP scale

    variation of the score of Clinical Abdominal assessment scale for Preterm infants, between 0 and 20 (higher scores meaning worse outcome)

    Measured: up to 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2023
  2. Study start15 Mar 2023
  3. Primary completion1 Sep 2023
  4. Study completion1 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05827679
Sponsor's protocol ID
RNI 2022 COLNE
Other IDs
2022-A02779-34
Acronym
ECAP
Status last verified
Apr 2023
First submitted
23 Mar 2023
Last updated
15 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Birth Complication and Digestive System Disease, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Abdominal assessment scale for Preterm infant (ECAP scale) (time frame: up to 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in